alexa Tablet Formulation of Levothyroxine Is Absorbed Less Well Than Powdered Levothyroxine
Pharmaceutical Sciences

Pharmaceutical Sciences

Journal of Pharmacovigilance

Author(s): Toshihide Yamamoto

Abstract Share this page

The comparative bioavailability of oral doses of levothyroxine (LT4) formulation taken as tablets, after being crushed, or chewed before swallowing has not been well studied. Three patients with hypothyroidism who showed persistent elevation of serum thyrotropin (TSH) despite taking 200, 150, and 125 μg of LT4 tablets per day are presented. They did not show signs and symptoms of gastrointestinal illness that could interfere with the absorption of LT4 nor history of such a condition. They did not concurrently take medications known to affect the absorption of LT4 from the gut. Their serum TSH levels normalized when the tablets were taken after being pulverized. The difference appeared attributable to the slow dissolution of the tablets in the gut of these patients.

This article was published in Thyroid and referenced in Journal of Pharmacovigilance

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version